S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)

Vuzix Corp (NASDAQ: VUZI) Stock is an Emerging AR Smart Glass Play

Thursday, December 10, 2020 | Jea Yu
Vuzix Corp (NASDAQ: VUZI) Stock is an Emerging AR Smart Glass Play Augmented reality smart glass maker Vuzix Corporation (NASDAQ: VUZI) stock has been a pandemic benefactor outperforming the benchmark S&P 500 index (NYSEARCA: SPY). It’s said that the COVID-19 pandemic has accelerated the migration and adoption of digital technologies and ecommerce by a decade within a year’s time. Remote, streaming, contactless and convenience are the core themes in the age of COVID. Just like the initial 3COM Palm Pilots and Apple (NASDAQ: AAPL) Newton tablets initially bombed, these precursors paved the way for mobile tablets to become a mainstream household consumer and commercial product now. The same may apply to augmented reality and smart glasses. The pandemic has given a resurgence to the utility of the smart glass technology, referred to as “optical see-through systems”, notably in the medical and commercial segments. The adoption is here to stay and likely grow moving forward in the “new normal”. Prudent investors can wait for opportunistic pullback price levels to gain exposure in this emerging trend.

Q3 FY 2020 Earnings Release

On Nov. 9, 2020, Vuzix reported its Q3 2020 results for the quarter ending September 2020. The Company reported an GAAP earnings-per-share (EPS) loss of (-$0.13) in-line with consensus analyst estimates. Revenues rose 156% year-over-year (YoY) to $2.78 million and up 15% sequentially. Follow-on orders continued to accelerate from Q2 primarily driven by existing and new customers in healthcare. Telemedicine, telehealth patient care, training and surgery continue to be an “important new business segment for Vuzix.”, according to CEO Paul Travers. Margins improved to 47% compared to 36% YoY. The Company ended the quarter with $24.9 million in cash and cash equivalents and $31 million in overall working capital.

Conference Call Takeaways

Vuzix CEO, Paul Travers, stated, “The COVID-19 pandemic has become a catalyst for much broader acceptance of enterprise smart glasses, resulting in shorter evaluation periods and increase customer adoptions.” He noted that along with healthcare, field service and manufacturing sectors are key growth drivers heading into strong record October sales. The OEM and Engineering Services business is actively engaged with five active programs collectively representing $700,000 in commitments. October has kicked off the fourth quarter with the highest single monthly sales in the Company’s history, “We’re seeing replenishment orders from resellers, follow-on orders from direct customers and a continued stream of inbound sales from new customers, as our core Smart Glass business continues to accelerate across the globe.” Travers noted, “We are just getting started with broader smart glasses adoption by enterprise users. Why send the person when you can send a pair of Vuzix Smart glasses? Deploying Vuzix Smart Glasses in enterprise is a safer, cheaper, faster and in many respects a better way of doing business.” Further noting that ,”the pandemic has forced the point.”

Enterprise Adoption of Vuzix Optical See-Through Systems

The Vuzix M400 accounted for the majority of sales. The M400 captures and streams industry-leading 4K at 30 frames-per-second HD streaming video with image stabilized and autofocusing camera on OLED display especially useful for field service workers. The voice controls built into the base operating system makes it a complete hands-free device. The glasses integrate with video conferencing platforms including Zoom Video (NASDAQ: ZM), Skype (NASDAQ: MSFT) , and Cisco WebEx (NASDAQ: CSCO). The M4000 provides a 5000-nit display providing double the field view of the M400. The Blade upgraded version includes built-in stereo audio features. The Company noted the “growing acceleration in adoption driven by business continuity plans and the urgent need to deliver remote expertise without having personnel on site.” Some of the notable customer wins include Clorox (NYSE: CLX), Pixee Medical and Medtronic (NYSE: MDT). Smart glasses being used from virtual ICU monitoring by doctors doing rounds, to knee replacement operation surgeries training, clinical trials, remote student learning to manufacturing operations support, and auditing. The Company continues to work with Verizon (NYSE: VZ) as a distributor for its EMS solutions bundling of hardware and 5G services focused on bringing “situational awareness technology” to public safety and first responders. Prudent investors that believe in the growth prospect from enterprise adoption of smart glasses can watch for opportunistic pullback levels in shares of Vuzix.

Vuzix Corp (NASDAQ: VUZI) Stock is an Emerging AR Smart Glass Play

 VUZI Opportunistic Pullback Levels

Using the rifle charts on the monthly and weekly time frames provides a broader view of the landscape for VUZI stock. The monthly rifle chart formed a mini pup breakout triggered above the monthly market structure low (MSL)triggered above $1.73. Shares peaked off the $5.27 Fibonacci (fib) level. The monthly 5-period moving average (MA) support at $4.16 needs to hold long enough for the weekly stochastic to cross up to trigger a monthly stochastic mini pup. The weekly rifle chart has pulled back with a stalled downtrend as the weekly stochastic decides to either crossover back up or form a mini inverse pup drop towards the 20-band. Since shares are trading over double the pre-COVID highs, prudent investors can wait for opportunistic pullback levels at the $3.89 fib, $3.41 fib, $3.08 fib and the $2.74 fib. Again, it is worth noting that the cheaper the entry, the better value can be derived. While the Company is finally hitting on all cylinders, much of the expectations are priced into the stock and thus deeper pullbacks are the best defense. Upside trajectories range from the $5.27 fib to the $7.80 fib.

Should you invest $1,000 in Vuzix right now?

Before you consider Vuzix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vuzix wasn't on the list.

While Vuzix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Vuzix (VUZI)1.6$11.29-2.4%N/A-23.52Buy$21.50
Apple (AAPL)2.8$146.92+0.1%0.60%28.75Buy$164.03
Zoom Video Communications (ZM)2.2$272.36-1.4%N/A82.28Hold$400.65
Microsoft (MSFT)3.0$299.35-0.1%0.75%37.19Buy$325.44
Cisco Systems (CSCO)2.9$56.73+0.1%2.61%22.69Buy$60.72
Medtronic (MDT)3.1$130.02-0.5%1.94%45.46Buy$144.24
The Clorox (CLX)2.7$164.56+1.3%2.82%29.70Hold$181.00
Verizon Communications (VZ)3.3$54.37-0.1%4.62%11.26Hold$60.75
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.